Updates in Amblyopia Treatment

Retina is producing Phase 3 results faster than ever, but FDA approval doesn't necessarily convey how a drug will fit into practice. Dr. Ehsan Rahimy joins host Dr. Jay Sridhar to unpack recent and somewhat puzzling trial results involving tyrosine kinase inhibitors, IL-6 inhibit ...  Show more

Artificial intelligence is rapidly recasting how we interact with our world and our patients. In today's epside, host Dr. Amanda Redfern welcomes Dr. Chris Kelly, Chief Health Information Officer at Oregon Health and Science University (OHSU), to provide an inside look at tools a ...  Show more

Go online to PeerView.com/CMG860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Intravitreal treatments have advanced rapidly to become the mainstay of therapy for DR/DME. Anti-VEGF agents and corticosteroid implants have demon ...  Show more

In this episode with speak with Bhavin Shah, an Optometrist from North London with a special interest in myopia management. He provides an overview of the literature regarding existing and future treatments and provides a personal insight into how he manages patients in whom p ...

This episode highlights a consensus statement that was published in a joint CME/CE publication in CRST and Modern Optometry in April 2023, in which 12 optometrists and ophthalmologists convened to discuss and vote on the importance of the optical correlation between pupil size an ...  Show more